Clinical Trial Update: CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the CMV-MVA Triplex vaccine given to stem cell donors to prevent cytomegalovirus viremia in recipients of allogeneic hematopoietic cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia
• Hodgkin Lymphoma
• Myelodysplastic Myeloproliferative Neoplasm
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Drugs mentioned

• CMV-MVA Triplex Vaccine (CMV-MVA Triplex Vaccine)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Accelerated Phase CML, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-01-31